46th Annual Shields Research Day
Theme: Revolutionizing Pain and Outcomes Research
What is Shields Research Day?
The overall purpose of our Annual Shields Day event is to bring together our clinical faculty, fellows, residents, and anesthesia assistants from the University-affiliated hospitals. Shields Research Day aims to provide a forum for updates on and stimulate further research into the frontiers of clinical science regarding anesthesia and related topics (e.g., critical care management, obstetrical anesthesia, pain management, etc.). We have been growing in recent years!
We aim to provide an excellent research and training opportunity for Anesthesia faculty, residents, fellows, graduate students, and anesthesia assistants who wish to keep abreast of current research initiatives in the field.
Our trainees (residents, fellows, and graduate students) have a unique opportunity to experience all the stages of presenting their peer-reviewed work at a scientific meeting, from the abstract writing and submission process to the poster design and oral presentation phase. The Annual Shields Research Day prepares trainees for a future role in academia under the guidance of experienced faculty mentors.
The goal is to create synergies for collaborative research (both clinical and basic science) that will enhance the work and advance knowledge beyond what each investigator can accomplish independently. The participants will have an opportunity to discuss topics of interest in the field of anesthesia and gain a better understanding of research methodologies.
Event Details
- Date: Friday, May 2, 2025
- Time: 7:30 a.m. - 3:30 p.m. EST
- Location: Park Hyatt Toronto
Key Dates and Deadlines for 2025
- Call for Abstracts: January 15, 2025
- Event Registration Opens: March 3, 2025
- Deadline for Submission of Abstracts: March 3, 2025
- Successful Applicants are Informed: April 2, 2025
- 46th Annual Shields Research Day: May 2, 2025
Program: TBA
Click to learn more on how to submit an abstract to Shields Research Day!
Keynote Speakers
Keynote Address by Sean Mackey, M.D., Ph.D.
Biography
Dr. Sean Mackey is the Redlich Professor and Chief of the Division of Stanford Pain Medicine. As a physician-scientist, he specializes in neuroimaging, psychophysics, public health, health policy, patient outcomes, and medical education. His work is guided by the mission "To Predict, Prevent and Alleviate Pain," focusing on understanding chronic pain, developing prevention methods, and discovering new therapies.
Dr. Mackey leads a multidisciplinary team using advanced tools like neuroimaging, genomics, and patient-reported outcomes. He has been the principal investigator on multiple NIH awards and holds two endowments supporting innovative research. With over 200 publications, Dr. Mackey is a respected author and lecturer in the field.
His current research concentrates on characterizing CNS mechanisms of pain and developing CHOIR, an open-source learning healthcare system for pain care. Dr. Mackey's team investigates novel pain therapies, including transcranial magnetic stimulation, virtual reality, and psychological approaches. Through his work, Dr. Mackey continues to advance the field of pain medicine and improve patients' lives.
Faculty Speaker
Lecture by James Khan, MSc, MD, FRCPC
Biography
Dr. James Khan is an Assistant Professor and Clinician-Scientist in the Department of Anesthesiology & Pain Medicine at the University of Toronto. He completed his medical school training at McMaster Medical School where he graduated as his class Valedictorian. He completed residency training in Anesthesiology at the University of Toronto and fellowship training in Pain Medicine at Stanford University. With a Master of Science in Clinical Epidemiology from McMaster University, Dr. Khan has published over 70 peer-reviewed scientific papers, many focusing on the transition from acute to chronic pain, and was named the 2020 United States Association for the Study of Pain Young Investigator of the Year. As the Director of the Persistent Breast Cancer Pain Clinic at Mount Sinai Hospital in Toronto, a national expert in the implantation of Peripheral Nerve Stimulators, and the Research Lead for the Division of Pain Medicine at UofT, Dr. Khan currently leads the PLAN Trial, an international multicentre randomized controlled trial involving 1,602 patients, which aims to evaluate whether an intraoperative intravenous lidocaine infusion can prevent persistent pain after breast cancer surgery.